✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous

EVOQ Remedies Ltd.

EVOQ

Market Cap
₹6 Cr.
P/E
0.00

EVOQ Remedies Ltd.

  • EVOQ Remedies
  • Dipna Pharma.
  • JFL Life Sciences

FAQs on EVOQ Remedies Ltd. Shareprice

EVOQ Remedies has given lower returns compared to its competitors.
EVOQ Remedies has grown at ~-44.84% over the last 3yrs while peers have grown at a median rate of -8.41%

EVOQ Remedies is not expensive.
Latest PE of EVOQ Remedies is 0, while 3 year average PE is 46.49.
Also latest EV/EBITDA of EVOQ Remedies is 0 while 3yr average is 4.79.

View FAQ's On Business

Growth Table

  • EVOQ Remedies Ltd.
  • Dipna Pharma.
  • JFL Life Sciences

Balance Sheet

  • EVOQ Remedies Ltd.
  • Dipna Pharma.
  • JFL Life Sciences

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • EVOQ Remedies Ltd.
  • Dipna Pharma.
  • JFL Life Sciences

Cash Flow

  • EVOQ Remedies Ltd.
  • Dipna Pharma.
  • JFL Life Sciences

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • EVOQ Remedies Ltd.
  • Dipna Pharma.
  • JFL Life Sciences

Quarterly Results

  • EVOQ Remedies Ltd.
  • Dipna Pharma.
  • JFL Life Sciences

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on EVOQ Remedies Ltd. Financials

Balance sheet of EVOQ Remedies is moderately strong.

Yes, The net debt of EVOQ Remedies is increasing.
Latest net debt of EVOQ Remedies is ₹0.07 Crs as of Mar-26.
This is greater than Mar-25 when it was -₹0.23 Crs.

No, profit is decreasing.
The profit of EVOQ Remedies is ₹0.09 Crs for Mar 2025, ₹0.45 Crs for Mar 2024 and ₹1.62 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
EVOQ Remedies latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech